Author

S. D. Himpsl

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

H. L. T. Mobley· 2 shared A. N. Brown· 1 shared A. Sintsova· 1 shared B. L. Moricz· 1 shared C. A. Sarkissan· 1 shared C. Alteri· 1 shared C. L. Holmes· 1 shared C. M. Kiser· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

H. L. T. Mobley

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Fitness Factor Genes Conserved within the Multi-species Core Genome of Gram-negative Enterobacterales Species Contribute to Bacteremia Pathogenesis

H. L. T. Mobley, M. T. Anderson, B. L. Moricz, G. S. Severin, C. L. Holmes, E. N. Ottosen, T. Eichler, S. Gupta, S. Paudel, R. Sinha, S. Mason, S. D. Himpsl, A. N. Brown, M. L. Gaca, C. M. Kiser, , M. A. Bachman

The paper identifies 18 conserved fitness genes in Enterobacterales species that contribute to bacteremia pathogenesis by testing mutants in a mouse model and finding attenuation in multiple organs.

PLOS Pathogens · Aug 23, 2024Peer-reviewedMicrobiology

Optimization of an Experimental Vaccine to Prevent Escherichia coli Urinary Tract Infection

V. S. Forsyth, S. D. Himpsl, S. N. Smith, C. A. Sarkissan, L. A. Mike, J. A. Stocki, A. Sintsova, C. Alteri, H. L. T. Mobley

This study optimizes an intranasal vaccine against UPEC UTI using dmLT adjuvant and Hma/IutA antigens, significantly reducing bladder colonization.

mBio · Apr 28, 2020Peer-reviewedMicrobiology